Skip links

Chronic Myelogenous Leukemia (CML)

What is Chronic Myelogenous Leukemia (CML)?

CML is a cancer of the myeloid cells caused by the BCR-ABL gene fusion (Philadelphia chromosome).

Role of Stem Cell Therapy:

HSCT is reserved for patients who fail tyrosine kinase inhibitors or present in advanced phases.

Medical Insight:

Although rare today, HSCT is still curative and necessary for a subset of patients.

Why consider stem cell storage for Chronic Myelogenous Leukemia (CML)?

When standard treatments fail, pre-stored stem cells provide a critical safety net.

Think ahead. Act now!